Navigation Links
Epizyme to Partner to Develop DOT1L Companion Diagnostic
Date:4/18/2013

CAMBRIDGE, Mass., April 18, 2013 /PRNewswire-USNewswire/ -- Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it has signed an agreement with Abbott, a global healthcare company, to develop a molecular companion diagnostic test for use with EPZ-5676. EPZ-5676, Epizyme's most advanced clinical product candidate, is an inhibitor targeting the DOT1L histone methyltransferase (HMT) for the treatment of mixed lineage leukemia (MLL-r), an aggressive genetically defined subtype of the two most common forms of acute leukemia, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

Under the agreement, Abbott will utilize its proprietary fluorescence in situ hybridization (FISH) technology to design a test to detect MLL genetic alterations that lead to the oncogenic (cancer causing) function of DOT1L. Epizyme will use Abbott's FISH-based test to help identify eligible patients for its DOT1L inhibitor.

About mixed lineage leukemia (MLL-r)
MLL-r is an aggressive subtype of two of the most common forms of acute leukemia, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), caused by a chromosomal translocation involving the MLL gene. Based on published research, the five-year overall survival rate for adult patients with the MLL-r subtype of AML ranges from approximately 5 to 24 percent. MLL-r occurs in both an adult population and an infant/pediatric population. At this time, there are no approved therapies specifically indicated for MLL-r.

About Epizyme, Inc.
Epizyme is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme has built a proprietary product platform that we use to create small molecule inhibitors of a 96-member class of enzymes known
'/>"/>

SOURCE Epizyme
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Epizyme to Present at Upcoming Conferences in February
2. Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics
3. Tria Beauty, Inc. and Ulta Announce New Retail Partnership
4. Richard Atkin to Join MedTech Nordic Investing & Partnering 2013
5. RoundTable Healthcare Partners and Argon Medical Devices Complete Acquisition of Angiotech Pharmaceuticals Interventional Products Business
6. Profil Institute and Mercodia Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials
7. Core Informatics and OpenEye Scientific Software Forge Partnership
8. Absorption Systems Partners with Synerzys to Promote Biopharmaceutics Classification System (BCS) Testing of Drugs
9. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
10. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive Today
11. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapeutics primarily in the ... medical needs, today reported its financial results for ... 2014, and provided a business update. ... "The past year has seen a steady growth ...
(Date:3/30/2015)...  Confirming its investment in the area of ... of Darmstadt,s announcement on the launch of the ... German government. Directed at developing ... as way to protect and prevent the brain ... anti-inflammatory and antioxidant activities of olive polyphenols, especially ...
(Date:3/29/2015)... 2015  Three-month paliperidone palmitate, an investigational atypical ... placebo in patients with schizophrenia, according to a ... in the Journal of the American ... Results of the study served as the basis ... for three-month paliperidone palmitate injection to treat schizophrenia ...
Breaking Medicine Technology:RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 2RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 3RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 4RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 5RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 6RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 7RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 8RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 9RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 10CreAgri Reaffirms Its Commitment to Neuroprotection and Alzheimer's Prevention in Light of German Research Project 2CreAgri Reaffirms Its Commitment to Neuroprotection and Alzheimer's Prevention in Light of German Research Project 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12
... 2011 Reportlinker.com announces that a new market research ... The 2011 US Coagulation Market ... comprehensive analysis of the US coagulation market, including: ... practice, as well as key economic, regulatory, demographic, social ...
... Mobile Dog Heart Health Tour is heading to Jacksonville for ... Johns Town Center from 11 a.m. to 3 p.m. on ... screenings in a soundproof medical unit, as well as educate ... http://photos.prnewswire.com/prnh/20110127/CG37742 ) Since early 2009, veterinarians on the ...
Cached Medicine Technology:Reportlinker Adds The 2011 US Coagulation Market 2Free Dog Heart Checks in Jacksonville 2Free Dog Heart Checks in Jacksonville 3
(Date:3/29/2015)... (PRWEB) March 30, 2015 Over 50 ... symptoms tied to undiagnosed autoimmune, thyroid, or hormone disorders. ... disorders, has personally treated hundreds of patients dealing with ... unaware of the treatment options for their ailments. Her ... solutions to women living with fatigue, brain fog, and ...
(Date:3/29/2015)... 29, 2015 Women’s Excellence , ... Secondary to their location in Birmingham, they now ... They continue to be affiliated with Crittenton, St. ... Menopause is a normal condition that all women experience ... of the changes a woman goes through either just ...
(Date:3/29/2015)... Nashville, TN (PRWEB) March 29, 2015 ... insurance that agencies promote nationally on the web can ... of permanent life insurance quotes can now be explored ... http://quotespros.com/life-insurance.html . , Learning the differences between what ... offers can be a challenge for some men and ...
(Date:3/29/2015)... March 29, 2015 The culmination of one ... coming when the Final Four invades Lucas Oil ... has been one filled with excitement, buzzer-beaters, and of course, ... busted, superstars have been made, and future professional products have ... down to the four teams that advanced through their regional ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 The ... clinical trials and research, manage data results and ... their clients reach regulation standards. Contract research organizations ... medical device manufacturing sectors. Industry operators provide clients ... to late-stage clinical research for Food and Drug ...
Breaking Medicine News(10 mins):Health News:How to Turn Mid-life into the Good Life 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Menopause 2Health News:Permanent Life Insurance Quotes Now Offered Through Web Search System at Insurer Website Online 2Health News:Cheap 2015 Final Four Tickets: Ticket Down Slashes Kentucky Wildcats and Wisconsin Badgers Final Four Tickets at Lucas Oil Stadium and Issues Valuable Promo Code 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 4
... Healthy, middle-aged smokers who take the most popular smoking cessation ... of being hospitalized with a heart attack or other serious ... Hopkins-led study suggests. "People want to quit smoking to ... they,re taking a drug that increases the risk for the ...
... Phoenix, AZ, USA July 4, 2011 VisionGate, ... the early detection of lung cancer, today announced that ... its LuCED test can improve the utility of low ... detection of lung cancer in high risk individuals. ...
... News) -- Staying hydrated is critical if you,re physically active ... so you need to assess your personal sweat rate, according ... "Sweat rate is very simple to calculate: weigh yourself ... half an hour and don,t drink or use the bathroom ...
... FRIDAY, July 1 (HealthDay News) -- Preschool children need to ... the true concept of counting, according to researchers. "We ... to involve counting. It,s only when children go beyond three ... are," lead author Elizabeth Gunderson, a graduate student in psychology ...
... , FRIDAY, July 1 (HealthDay News) -- A new ... a certain type of learning remarkable staying power. Over ... face or pattern from a larger group of images. They ... practice. When they were tested again one to two years ...
... citywide study published online in today,s issue of ... disparities in the use of clot-busting drugs to treat acute ... According to the study,s results, significantly fewer black patients receive ... emergency care and the presence of medical conditions that exclude ...
Cached Medicine News:Health News:Smokers using varenicline to quit the habit at greater risk of heart attack 2Health News:IASLC: Adjunctive use of 3-D imaging system increases utility of CT lung cancer screening 2Health News:IASLC: Adjunctive use of 3-D imaging system increases utility of CT lung cancer screening 3Health News:How to Stay Hydrated in Hot Weather 2Health News:Understanding Numbers Isn't as Simple as 1, 2, 3 2Health News:When It Comes to Memory, Practice Seems to Make Perfect 2Health News:Citywide study shows racial disparities in emergency stroke treatment 2
... High performance plus simple ... gentle and efficient washing ... is performed with minimum ... cells while membrane bound ...
Stat Fax 2600 is fully automatic microplate washer....
The Microtech Microplate Washer (220 V) is a flexible and ultra compact microplate washer. The system offers a wide choice of washing functions and sequences designed to handle most any microplate ap...
... a powerful, compact and programmable 2 ... vacuum and dispensing pumps. Dispense and ... vertical and horizontal needle positioning in ... wash and waste bottles and vacuum ...
Medicine Products: